"The vision of a research scientist takes on social and commercial expressions." This in short explains the genesis and growth of Sami Labs Limited
Dr. Muhammed Majeed, Founder & Managing Director of Sami Labs Limited, was born and brought up in Kerala ( India ). It was his urge to establish himself not just as a scientist but also an entrepreneur that made him fly beyond his home turf. So in 1975, after obtaining his degree in pharmacy, he proceeded to USA where he completed his MS in Industrial Pharmacy from Long Island University, New York after which he took his doctorate in the same field from St John's University, New York. Then he gained valuable experience working in Pfizer Inc, Carter-Wallace and Paco Research.
In 1988, Dr Majeed established Sabinsa Corporation in the state of New Jersey, USA with the objective of importing and marketing generic drugs into the US for the drug molecules coming off patent.
Very soon he introduced into the US market a new line of products based on Indian herbal plants. It was Dr Muhammed Majeed who introduced to the Americans that Ayurveda from India can act as a complete curative to their various ailments. The persistent efforts made by Dr Majeed in the early nineties in the field of Ayurveda did reap benefits among the Americans. They started recognizing the potential of Ayurveda and termed it the Alternative medicine. By 2000 it became popular as the Complementary medicine and now it is called as the Integrated medicine.
To facilitate the increased demand for innovative application-based products, Sami Labs Limited (formerly known as Sami Chemicals & Extracts Limited) was set up in 1991 at Singasandra in Bangalore ( India ) as a research and development facility. Today the main thrust and focus of Sami is on new product development and market oriented research.
To cater to the expanding global market, Sami Labs has presence and strategic alliances in USA, Europe, Japan, Australia, Middle East, South Africa, China, Vietnam, and Philippines.
The global revenue of the company stood at USD 65 million (for 2009), with an employee strength of 150 people Internationally, more than 750 in India and over 110 scientists worldwide.